glp-1 for nash can glp 1 help fatty liver Multiple target tissue effects of analogues on non-alcoholic disease (NAFLD) and non-alcoholic steatohepatitis (NASH) GLP-1 Receptor Agonists Non-Alcoholic – Non-alcoholic fatty liver disease risk

Ozempic leads to greater weight loss, while Contrave may be more effective for emotional or reward-driven eating

I explore all this in a feature story published today, which marks the kick off of a new series from The Globe and Mail called Skinny Inc, about the big business of weight-loss drugs: Also published today is a companion piece from my colleague Kelly Grant who digs deeper into the research and patient experience of these drugs: We have more coming in the series over the coming weeks, including stories on influencers, insurance coverage, the effect on the food industry and more

A: The most common side effects are gastrointestinal issues, such as nausea, vomiting, and bloating

Longer-acting GLP-1 analogs that can be administered once each month are currently in clinical trials